Mark Milford

Mark Milford is currently the Director of Analytical at Eli Lilly and Company, where they provide strategic oversight for large molecule commercialization activities and mentor colleagues across multiple global sites. They previously held roles such as Senior Advisor - Analytical and Associate Senior Consultant Quality at the Kinsale Manufacturing Site, contributing to regulatory documentation and method validation. Mark's earlier experience includes positions at Emergent BioSolutions and PharmAthene, managing analytical development for vaccines. They earned a PhD in Protein Biochemistry and a BSc in Chemistry and Biochemistry from the University of Southampton.